PanTheryx Overview
- Year Founded
-
2007
- Status
-
Private
- Employees
-
77
- Latest Deal Type
-
PE Growth
- Financing Rounds
-
12
- Investments
-
4
PanTheryx General Information
Description
Provider of intestinal research and medical nutrition products intended to address serious gastrointestinal microbiome-related health conditions. The company is focused on pharmaceutical research, development, and commercialization of products that target the gastrointestinal microbiome, enabling pharmaceutical and consumer healthcare companies to deliver safe and efficient anti-diarrheal medicine.
Contact Information
Website
www.pantheryx.comCorporate Office
- 4845 Pearl East Circle
- Suite 101
- Boulder, CO 80301
- United States
Corporate Office
- 4845 Pearl East Circle
- Suite 101
- Boulder, CO 80301
- United States
PanTheryx Timeline
PanTheryx Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
PanTheryx Comparisons
Industry
Financing
Details
PanTheryx Competitors (3)
One of PanTheryx’s 3 competitors is Anatara Lifesciences, a Formerly VC-backed company based in Adelaide, Australia.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Anatara Lifesciences | Formerly VC-backed | Adelaide, Australia | ||||
| Vitaflo Deutschland | Corporation | Hessen, Germany | ||||
| Adare Pharma Solutions | Private Equity-Backed | Philadelphia, PA |
PanTheryx Patents
PanTheryx Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026072929-A1 | Compositions for treating gastrointestinal side effects of weight loss and diabetes medications | Pending | 27-Sep-2024 | ||
| AU-2022227009-A1 | Stabilized colostrum compositions | Inactive | 26-Feb-2021 | ||
| EP-4297589-A1 | Stabilized colostrum compositions | Inactive | 26-Feb-2021 | ||
| US-20220362303-A1 | Stabilized colostrum compositions | Inactive | 26-Feb-2021 | ||
| WO-2022183012-A1 | Stabilized colostrum compositions | Inactive | 26-Feb-2021 | A61K35/20 |
PanTheryx Signals
PanTheryx Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
PanTheryx Investments (4)
PanTheryx’s most recent deal was a Buyout/LBO with Trubiotics. The deal was made on 28-Feb-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Trubiotics | 28-Feb-2021 | Buyout/LBO | Other Consumer Non-Durables | ||
| Greenteaspoon | 14-Oct-2020 | Buyout/LBO | Biotechnology | ||
| APS BioGroup (Pharmaceuticals and Biotechnology) | 14-Feb-2017 | Buyout/LBO | Biotechnology | ||
| La Belle Associates | 01-Mar-2016 | Buyout/LBO | Other Commercial Products |
PanTheryx Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Trubiotics | Boulder, CO | 2007 |
PanTheryx FAQs
-
When was PanTheryx founded?
PanTheryx was founded in 2007.
-
Where is PanTheryx headquartered?
PanTheryx is headquartered in Boulder, CO.
-
What is the size of PanTheryx?
PanTheryx has 77 total employees.
-
What industry is PanTheryx in?
PanTheryx’s primary industry is Biotechnology.
-
Is PanTheryx a private or public company?
PanTheryx is a Private company.
-
What is PanTheryx’s current revenue?
The current revenue for PanTheryx is .
-
How much funding has PanTheryx raised over time?
PanTheryx has raised $199M.
-
Who are PanTheryx’s investors?
Pegasus Capital Advisors has invested in PanTheryx.
-
Who are PanTheryx’s competitors?
Anatara Lifesciences, Vitaflo Deutschland, and Adare Pharma Solutions are competitors of PanTheryx.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process